1[1]Scorsin M, Hagege A, Vilquin, JT, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg, 2000,119:1169-1175.
2[2]Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performnce after skeletal myoblast transplantation. Nat Med, 1998, 4: 929-933.
3[4]Dib N, Diethrich EB, Campbell A, et al. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. J Endovasc Ther, 2002, 9:313-319.
4[5]Ghostine S, Carrion C, Souza LC, et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation,2002,106( 12 Suppl 1): I131-I136.
5[6]Suzuki K, Murtuza B, Suzuki N, et al. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicicn-induced heart failure. Circulation, 2001, 104 ( 12Suppl 1) : I213-I217.
6[7]Jain M, DerSimonian H, Brenner DA, et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation,2001,103:1920-1927.
7[8]Lequerica JL, Mirabet V, Montero JA, et al. In vitro pro liferation, differentiation and immuno-magnetic bead purifi cation of human myoblasts. Ann Transplant, 1999,4: 103-108.
8[9]Pouzet B, Vilquin JT, Hagege AA, et al. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized? Circulation, 2000,102 ( 19 Suppl 3): 210-215.
31，Li ZL, Mericskay M,Agbulut O, et al.Desmin is essential for the tensile strength and integrity of myofibrilsbut not for myogenic commitment, differentiation, and fusion of skeletal muscle. J CellBiol, 1997, 139(1):129-144.
42，Schaper J, Froede R, Hein St, et al. Impairment of the myocardial ultrastructure andchanges of the cytoskeleton in dilated cardiomyopathy. Circulation, 1991, 83(2):504-514.
53，Dorfman J, Duong M, Zibaitis A, et al. Myocardial tissue engineering with autologousmyoblast implantation. J Thorac Cardiovasc Surg, 1998, 116(3):744-751.
64，Schwarz ER, Patterson M, Kloner RA. Cardiomyocyte transplantation——a cellreplacement for repair of myocardial infarction? Z Kardiol, 1998, 87(1):1-7.
75，Smith MJL, Mcgeachie JK. The identification of myogenic cells in skeletal muscle, withemphasis on the use of tritiated thymidine autoradiography and desmin antibodies. J Anat,1998, 192(1):161-171.
86，Reinecke H, Zhang M, Bartosek T, et al. Survival, integration, and differentiation ofcardiomyocyte grafts: a study in normal and injured rat hearts. Circulation, 1999, 100(7)：193-202.
97，Murry CE, Wiseman RW, Schwartz SM, et al. Skeletal myoblast transplantation for repairof myocardial necrosis. J Clin Invest, 1996, 98(11):2512-2523.
108，Robinson SW, Cho PW, Levitsky HI, et al. Arterial delivery of genetically labelledskeletal myoblasts to the murine heart:long-term survival and phenotypic modification ofimplanted myoblasts. Cell Transplant, 1996, 5(1):77-91.
